StockMarketWire.com - Regenerative medicine developer Collagen Solutions said its subsidiaries in the US and New Zealand had received a mix of loan and grant funding based on those governments' Covid-19 economic support programmes.
The US business received $240,000 in US government-backed loan funding through one of the company's banking providers.
Collagen Solutions NZ also received $NZ35k from the New Zealand Ministry for Social Development's Wage Subsidy Scheme.
'The company continues to pursue additional potential non-dilutive sources of cash including various governments' Covid-19 loans and grants,' Collagen Solutions said.
At 1:42pm: [LON:COS] Collagen Solutions Plc share price was +0.25p at 3.15p
Story provided by StockMarketWire.com
Shares Magazine
Shares is the leading weekly publication for retail investors. It is packed with investment ideas, news and educational material to help build and run portfolios and get more from your money.
Investor Events
Shares puts on free Investor Events throughout the year across the country. They provide an opportunity for investors to learn more about companies on the stock market and hear from a range of investment experts including fund managers and Shares journalists.